Genexine Inc (095700) — Cash Flow-to-Debt Ratio
Genexine Inc (095700) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of ₩-2.97 Billion could theoretically repay 0% of its total liabilities (₩106.21 Billion) in one year. Explore long-term investment intensity of Genexine Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genexine Inc Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Genexine Inc across 14 annual periods. Also explore how large is Genexine Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Genexine Inc (2009–2024)
Year-by-year debt coverage analysis for Genexine Inc. For market capitalisation and broader financial context, see 095700 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | ₩-1.65 Billion | ₩83.36 Billion | ▲ +95.9% |
| 2023 | -0.48x | ₩-38.05 Billion | ₩79.68 Billion | ▼ -35.1% |
| 2022 | -0.35x | ₩-39.80 Billion | ₩112.63 Billion | ▼ -230.3% |
| 2021 | -0.11x | ₩-12.75 Billion | ₩119.12 Billion | ▲ +71.1% |
| 2020 | -0.37x | ₩-22.69 Billion | ₩61.30 Billion | ▲ +45.4% |
| 2019 | -0.68x | ₩-41.57 Billion | ₩61.27 Billion | ▼ -83.7% |
| 2018 | -0.37x | ₩-20.05 Billion | ₩54.30 Billion | ▲ +62.1% |
| 2017 | -0.97x | ₩-26.10 Billion | ₩26.83 Billion | ▼ -96.5% |
| 2016 | -0.50x | ₩-14.10 Billion | ₩28.47 Billion | ▼ -392.5% |
| 2015 | -0.10x | ₩-1.64 Billion | ₩16.33 Billion | ▼ -205.8% |
| 2012 | 0.10x | ₩1.67 Billion | ₩17.55 Billion | ▲ +141.4% |
| 2011 | -0.23x | ₩-3.48 Billion | ₩15.14 Billion | ▲ +44.1% |
| 2010 | -0.41x | ₩-4.62 Billion | ₩11.24 Billion | ▼ -5091.0% |
| 2009 | 0.01x | ₩35.23 Million | ₩4.28 Billion | — |